Telephone calls
|
130
|
102
|
58
|
5-Item-Questionnaire positiv
|
49 (37.7%)
|
26 (25.5%)
|
17 (29,3%)
|
Outpatient visits
|
49
|
26
|
17
|
Echocardiography,
|
n = 49
|
n = 26
|
n = 16
|
RVSP >/=35 mm Hg
|
10 (20.4%)
|
3 (11.5%)
|
3 (18.8%)
|
REVSP < 35 mm Hg/ not detectable
|
39 (79.6%)
|
23 (88.5%)
|
13 (81.25%)
|
Cardiopulmonary exercise testing,
|
n = 34
|
n = 15
|
n = 9
|
Abnormal pulmonary perfusion suspected
|
12 (35.28%)
|
4 (26.7%)
|
1 (11.1%)
|
Further evaluation
|
21
|
7
|
4
|
CTEPH/CTPVD proven per visit
|
5(3.85)/2(1.5%)
|
3(2.94/1(0.98%)
|
0/0.0%)
|
CTEPH/CTPVD proven, all patients
|
5(3.85%)/2(1.5%)
|
8(6.2%)/3(2.3%)
|
8(6.2%)/3(2.3%)
|